Early patient experiences with montelukast orally disintegrating tablets in Japan: a cross-sectional survey of treatment satisfaction in patients with asthma and/or allergic rhinitis

References

• The Global Asthma Report. Auckland, New Zealand: Global Asthma Network, 2014. Available at: http://www.globalasthmareport.org/resources/Global_Asthma_Report_2014.pdf [Last accessed 22 June 2016]
   Google Scholar
• Loftus P, Wise S. Epidemiology of asthma. Curr Opin Otolaryngol Head Neck Surg 2016;24:245-9
   PubMed Web of Science ®Google Scholar
• Fukutomi Y, Nakamura H, Kobayashi F, et al. Nationwide cross-sectional population-based study on the prevalences of asthma and asthma symptoms among Japanese adults. Int Arch Allergy Immunol 2010;153:280-7
   PubMed Web of Science ®Google Scholar
• Ohta K, Ichinose M, Nagase H, et al. Japanese guideline for adult asthma 2014. Allergol Int 2014;63:293-333
   PubMed Web of Science ®Google Scholar
• Moorman JE, Akinbami LJ, Bailey CM, et al. National surveillance of asthma: United States, 2001–2010. National Center for Health Statistics. Vital Health Stat 2012;3:1-58
   Google Scholar
• Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004;59:469-78
   PubMed Web of Science ®Google Scholar
• Gibson J, Loddenkemper R, Sibille Y, et al. The European Lung White Book: Respiratory Health and Disease in Europe. Lausanne, Switzerland: European Respiratory Society, 2013
   Google Scholar
• Hojo M, Ohta K, Iikura M, et al. The impact of co-existing seasonal allergic rhinitis caused by Japanese Cedar Pollinosis (SAR-JCP) upon asthma control status. Allergol Int 2015;64:150-5
   PubMed Web of Science ®Google Scholar
• Joshi AV, Madhavan SS, Ambegaonkar A, et al. Association of medication adherence with workplace productivity and health-related quality of life in patients with asthma. J Asthma 2006;43:521-6
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83
   PubMed Web of Science ®Google Scholar
• Lanier BQ, Nayak A. Prevalence and impact of nighttime symptoms in adults and children with asthma: a survey. Postgrad Med 2008;120:58-66
   PubMed Web of Science ®Google Scholar
• Oh E. The relationship between disease control, symptom distress, functioning, and quality of life in adults with asthma. J Asthma 2008;45:882-6
   PubMed Web of Science ®Google Scholar
• Ampon RD, Williamson M, Correll PK, et al. Impact of asthma on self-reported health status and quality of life: a population based study of Australians aged 18–64. Thorax 2005;60:735-9
   PubMed Web of Science ®Google Scholar
• Jaruvongvanich V, Mongkolpathumrat P, Chantaphakul H, et al. Extranasal symptoms of allergic rhinitis are difficult to treat and affect quality of life. Allergol Int 2016;65:199-203
   PubMed Web of Science ®Google Scholar
• Bousquet PJ, Demoly P, Devillier P, et al. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 2012;160:393-400
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Bourdin A, Gras D, Vachier I, et al. Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax 2009;64:999-1004
   PubMed Web of Science ®Google Scholar
• Ohta K, Bousquet PJ, Aizawa H, et al. Prevalence and impact of rhinitis in asthma. SACRA, a cross-sectional nation-wide study in Japan. Allergy 2011;66:1287
   PubMed Web of Science ®Google Scholar
• Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049-57
   PubMed Web of Science ®Google Scholar
• Price D, Harrow B, Small M, et al. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J 2015;8:26
   PubMed Web of Science ®Google Scholar
• Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015;46:622-39
   PubMed Web of Science ®Google Scholar
• Small P, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol 2011;7(Suppl 1):S3
   Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention, 2016. Available at: http://ginasthma.org/gina-reports/[Last accessed 12 October 2016]
   Google Scholar
• Paggiaro P, Bacci E. Montelukast in asthma: a review of its efficacy and place in therapy. Therap Adv Chronic Dis 2011;2:47-58
   PubMedGoogle Scholar
• Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis. Drugs 2007;67:887-901
   PubMed Web of Science ®Google Scholar
• Price DB, Swern A, Tozzi CA, et al. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 2006;61:737-42
   PubMed Web of Science ®Google Scholar
• Virchow JC, Bachert C. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir Med 2006;100:1952-9
   PubMed Web of Science ®Google Scholar
• Reiss T, Chervinsky P, Dockhorn R, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch Intern Med 1998;158:1213-20
   PubMed Web of Science ®Google Scholar
• Keith P, Koch C, Djandi M, et al. Montelukast as add-on therapy with inhaled corticosteroids or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir 2009;16(Suppl A):17-24A
   Google Scholar
• Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol 1998;50:375-82
   PubMed Web of Science ®Google Scholar
• Andersen O, Zweidorff OK, Hjelde T, et al. [Problems when swallowing tablets. A questionnaire study from general practice]. Tidsskr Nor Laegeforen 1995;115:947-9
   PubMedGoogle Scholar
• Yamamoto S, Taniguchi H, Hayashi H, et al. How do tablet properties influence swallowing behaviours? J Pharm Pharmacol 2014;66:32-9
   PubMed Web of Science ®Google Scholar
• Quinn HL, Hughes CM, Donnelly RF. Novel methods of drug administration for the treatment and care of older patients. Int J Pharm 2016: 512:366-73
   PubMed Web of Science ®Google Scholar
• Roger Reig A, Plazas Fernández MJ, Galván Cervera J, et al. Acceptance survey of a fast dissolving tablet pharmaceutical formulation in allergic patients. Satisfaction and expectancies. Allergol Immunopathol (Madr) 2006;34:107-12
   PubMedGoogle Scholar
• Murphy AC, Proeschel A, Linnett ME, et al. P174 Identifying non-adherence with asthma medication and the relationship to clinical outcomes amongst adults with difficult-to-control asthma. Thorax 2010;65(Suppl 4):A151
   Web of Science ®Google Scholar
• Suzuki T, Saito I, Adachi M, et al. Influence of patients’ adherence to mediation, patient background and physicians’ compliance to the guidelines on asthma control. Yakugaku Zasshi 2011;131:129-38
   PubMed Web of Science ®Google Scholar
• Horne R, Price D, Cleland J, et al. Can asthma control be improved by understanding the patient’s perspective? BMC Pulm Med 2007;7:8
   PubMedGoogle Scholar
• Roger A, Fortea J, Mora S, et al. Patient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitis. Expert Rev Pharmacoecon Outcomes Res 2008;8:337-42
   PubMedGoogle Scholar
• Roger A, Fortea J, Mora S, et al. Ebastine fast-dissolving tablets versus regular tablets: acceptability and preference in patients with allergic rhinitis. Expert Rev Clin Pharmacol 2008;1:381-9
   PubMedGoogle Scholar
• Bharmal M, Payne K, Atkinson MJ, et al. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes 2009;7:36
   PubMed Web of Science ®Google Scholar
• Sofianou A, Martynenko M, Wolf MS, et al. Asthma beliefs are associated with medication adherence in older asthmatics. J Gen Intern Med 2013;28:67-73
   PubMed Web of Science ®Google Scholar
• Barbosa CD, Balp MM, Kulich K, et al. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence 2012;6:39-48
   PubMed Web of Science ®Google Scholar
• Bourdin A, Halimi L, Vachier I, et al. Adherence in severe asthma. Clin Exp Allergy 2012;42:1566-74
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004;2:12
   PubMedGoogle Scholar